These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1962 related items for PubMed ID: 7955458

  • 21. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S, Akhtar N, Ahmad J.
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [Abstract] [Full Text] [Related]

  • 22. Age, insulin, SHBG and sex steroids exert secondary influence on plasma leptin level in women.
    Milewicz T, Krzysiek J, Janczak-Saif A, Sztefko K, Krzyczkowska-Sendrakowska M.
    Endokrynol Pol; 2005; 56(6):883-90. PubMed ID: 16821206
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Serum total renin is elevated in women with polycystic ovarian syndrome.
    Jaatinen TA, Matinlauri I, Anttila L, Koskinen P, Erkkola R, Irjala K.
    Fertil Steril; 1995 May; 63(5):1000-4. PubMed ID: 7720907
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S, van der Spuy ZM.
    Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
    [Abstract] [Full Text] [Related]

  • 30. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS, Rouzi AA.
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [Abstract] [Full Text] [Related]

  • 31. Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.
    Mejia-Montilla J, Álvarez-Mon M, Reyna-Villasmil E, Torres-Cepeda D, Santos-Bolívar J, Reyna-Villasmil N, Suarez-Torres I, Bravo-Henríquez A.
    Endocrinol Nutr; 2015 Jan; 62(1):31-7. PubMed ID: 25458401
    [Abstract] [Full Text] [Related]

  • 32. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J, Bergh T, Berne C, Lithell H.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [Abstract] [Full Text] [Related]

  • 33. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A, Mandeli J, Fluhr H, Dobrjansky A.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [Abstract] [Full Text] [Related]

  • 34. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N.
    Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
    [Abstract] [Full Text] [Related]

  • 35. Ultrasonography of the ovaries and its correlation with clinical and endocrine parameters in infertile women with PCOS.
    Sikka P, Gainder S, Dhaliwal LK, Bagga R, Sialy R, Sahdev S.
    Int J Fertil Womens Med; 2007 Jul; 52(1):41-7. PubMed ID: 17987887
    [Abstract] [Full Text] [Related]

  • 36. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
    Calzada M, López N, Noguera JA, Mendiola J, Hernández AI, Corbalán S, Sanchez M, Torres AM.
    J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
    [Abstract] [Full Text] [Related]

  • 37. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome.
    Eldar-Geva T, Spitz IM, Groome NP, Margalioth EJ, Homburg R.
    Hum Reprod; 2001 Dec; 16(12):2552-6. PubMed ID: 11726573
    [Abstract] [Full Text] [Related]

  • 38. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E, Uçok K, Akgün L, Köken G, Sahin FK, Arioz DT, Baş O.
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [Abstract] [Full Text] [Related]

  • 39. Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus.
    Kelestimur F, Unluhizarci K, Baybuga H, Atmaca H, Bayram F, Sahin Y.
    Fertil Steril; 2006 Aug; 86(2):405-10. PubMed ID: 16762349
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 99.